Zinc finger protein GLI2 (GLI2) mRNA (GLI2 mRNA)

Zinc finger protein GLI2 (GLI2) mRNA is the transcript of the GLI2 gene, which encodes a critical transcription factor in the Hedgehog (Hh) signaling pathway [1]. The GLI2 protein acts as a primary mediator of Hh signaling, transitioning from a cytoplasmic complex to the nucleus to activate target genes involved in cell cycle progression, epithelial-mesenchymal transition, and stem cell maintenance [2]. Overexpression of GLI2 mRNA is a hallmark of several cancers, particularly those resistant to Smoothened (SMO) inhibitors, such as advanced basal cell carcinoma and medulloblastoma [3]. Because GLI2 acts downstream of SMO, targeting its mRNA with antisense oligonucleotides (ASOs) or RNA interference (RNAi) provides a therapeutic advantage by silencing the pathway even in the presence of SMO mutations [4]. Experimental agents like IONIS-GLI2Rx have been developed to specifically bind and promote the degradation of GLI2 mRNA, thereby reducing the oncogenic protein load [5]. Despite its potential, therapeutic application faces challenges such as the requirement for precise delivery systems and the risk of disrupting normal developmental processes or tissue repair mechanisms that rely on Hh signaling [6]. Furthermore, the high sequence homology between GLI family members necessitates high specificity in drug design to avoid unintended silencing of related transcripts [1].

Other names

GLI-Kruppel family member 2 mRNATax helper protein 1 mRNATHP mRNAHPE9 mRNAZinc finger protein GLI2 transcript

Antisense oligonucleotide-mediated degradation of mRNA via RNase H recruitment or RNA interference (RNAi) to prevent translation of the GLI2 transcription factor.